Chronic Illness Info Line is categorized under Blood Related Health Services in Pittsburgh, PA and active since 1996.
Chronic Illness Info Line was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 621991 by the NAICS.
If you are seeking more information, feel free to contact Carol Lynn at the company’s single location by writing to 1515 Locust St # 709, Pittsburgh, Pennsylvania PA 15219 or by phoning (559) 438-4515. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chronic Illness Info Line |
| Contact Person: | Carol Lynn |
| Address: | 1515 Locust St # 709, Pittsburgh, Pennsylvania 15219 |
| Phone Number: | (559) 438-4515 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621991 |
| Share This Business: |
Chronic Illness Info Line was started in 1996 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 621991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Carol Lynn for inquiries that concern Chronic Illness Info Line by calling the company number (559) 438-4515, as your correspondence is most welcome. Additionally, the physical location of the single location of Chronic Illness Info Line can be found at the coordinates as well as the street address 1515 Locust St # 709 in Pittsburgh, Pennsylvania 15219.
For its online presence, you may visit Chronic Illness Info Line’s website at and engage with its social media outlets through on Twitter and on Facebook.